Skip to main content
OpenTrials

Clinical trial condition

Neisseriaceae Infections

Explore clinical trials studying Neisseriaceae Infections. Study availability and eligibility vary by location and protocol.

403 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Neisseriaceae Infections trial results

Completed

Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine

NCT04707391

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Banning, California, United States
  • GSK Investigational Site Chula Vista, California, United States
  • GSK Investigational Site West Covina, California, United States
View all 69 locations
View Trial Details
Completed

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

NCT03691610

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Alabama Clinical Therapeutics Site Number : 8400036 Birmingham, Alabama, United States
  • Southeastern Pediatric Associates Site Number : 8400009 Dothan, Alabama, United States
  • MedPharmics, LLC - Phoenix Site Number : 8400013 Phoenix, Arizona, United States
  • Emmaus Research Center, Inc Site Number : 8400019 Anaheim, California, United States
View all 47 locations
View Trial Details
Completed

A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea

NCT04010539

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Communicable Diseases, +8 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Palm Springs, California, United States
  • GSK Investigational Site DeLand, Florida, United States
  • GSK Investigational Site Orlando, Florida, United States
View all 51 locations
View Trial Details
Completed

Effectiveness of GlaxoSmithKline Biologicals S.A's Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults

NCT04502693

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Glendale, Arizona, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Bell Gardens, California, United States
View all 112 locations
View Trial Details
Completed

Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection

NCT04553068

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Chlamydia, +14 more
Locations
  • Cahaba Medical Care Birmingham, Alabama, United States
  • Mobile Obstetrics & Gynecology, P.C. Mobile, Alabama, United States
  • Marchand OBGYN Mesa, Arizona, United States
  • Onyx Clinical Research Peoria, Arizona, United States
View all 98 locations
View Trial Details
Completed

Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

NCT03673462

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Birmingham Pediatric Associates-Site Number:8400049 Birmingham, Alabama, United States
  • Southeastern Pediatric Associates-Site Number:8400034 Dothan, Alabama, United States
  • MedPharmics, LLC - Phoenix-Site Number:8400043 Phoenix, Arizona, United States
  • Northwest Arkansas Pediatric Clinic-Site Number:8400042 Fayetteville, Arkansas, United States
View all 69 locations
View Trial Details
Completed

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom

NCT03632720

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Investigational Site Number :8260024 Newquay, Cornwall, United Kingdom
  • Investigational Site Number :8260009 Penzance, Cornwall, United Kingdom
  • Investigational Site Number :8260013 Torpoint, Cornwall, United Kingdom
  • Investigational Site Number :8260010 Exeter, Devon, United Kingdom
View all 13 locations
View Trial Details

Related conditions